People exposed to proton‐pump inhibitors shortly preceding COVID‐19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study
Kodvanj et al., British Journal of Clinical Pharmacology, doi:10.1111/bcp.15525
https://c19early.org/kodvanj.html